By Bob Mitchell

Saying that Malvern-based Trice Medical’s recent launch of mi-ultra® and acquisition of SegWAY Orthopedics (SegWAY) will spark further innovative technologies that generate value to patients, physicians and payers, Mark Foster was recently named president and CEO.

“[My] mission is to build a great company that enhances quality of life,” Foster said after his appointment, which takes effect on June 30.

Foster joined Trice in 2016 as vice president of global sales and was named president of the company in March 2018. Foster will replace CEO Jeffrey O’Donnell, Sr. who is retiring, but will continue in a strategic advisor role.

O’Donnell said he is “proud of the whole team at Trice Medical and what we have achieved in the past six years. Mark joined Trice with a strong set of ‘big company skills’ – quickly adding value while also learning how different ‘start-ups’ are. I look forward to assisting him in his transition to this new role as the CEO of an emerging growth company.”

Gary Kurtzman, chair of the board, said in a statement that, “Jeff’s passion and drive have gotten us to this point. We will continue to leverage his skills and expertise as we enter the next stage of expansion and growth under Mark’s leadership.”

The company’s in-office mi-eye® or mi-ultra® procedure allows the patient and surgeon to get instant, accurate information and the recently acquired SegWAY, gives the Trice a diversified portfolio to treat patients with many different soft-tissue injuries, including the rapidly growing Endoscopic Carpal Tunnel Market.